Higher Buprenorphine Dose Increases Likelihood of Staying in Treatment
THURSDAY, Sept. 21, 2023 -- Patients initiating buprenorphine treatment for opioid use disorder who are prescribed a 24-mg dose are more likely to remain in treatment longer than those prescribed 16 mg, according to a study published online Sept. 18...
Source: Drugs.com - Pharma News - September 21, 2023 Category: Pharmaceuticals Source Type: news

Treatment Failure Similar for Amoxicillin +/ − Clavulanate for Pediatric Acute Sinusitis
THURSDAY, Sept. 21, 2023 -- There is no difference in the risk for treatment failure for outpatient children with acute sinusitis treated with amoxicillin-clavulanate compared with amoxicillin, according to a study published in the Sept. 19 issue of...
Source: Drugs.com - Pharma News - September 21, 2023 Category: Pharmaceuticals Source Type: news

How Wastewater Testing Can Help Tackle America ’ s Opioid Crisis
Among the many lasting legacies of COVID-19 may be a newfound appreciation for the value of what we flush down the toilet and wash down the drain. Wastewater can be a rich source of information about infectious diseases, like COVID-19, as well as flu, respiratory syncytial virus (RSV), mpox and polio, since pathogens like viruses are shed in feces, urine and saliva, all of which is drained into sewage treatment plants. Sampling that water is a good way to screen for certain viruses, and, as more people bypass the medical system and labs in favor of testing themselves at home for things like COVID-19, health agencies lik...
Source: TIME: Health - September 21, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Pain Evaluated as Pyoderma Gangrenosum Outcome Measure Pain Evaluated as Pyoderma Gangrenosum Outcome Measure
According to researchers, this is the first minimal important difference (which can help determine whether patients are responding to treatment) that has been calculated for an ulcerative skin condition.Medscape Medical News
Source: Medscape Allergy Headlines - September 21, 2023 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

Crocodile bites, the Plague and an 'excessive sex drive': All the WEIRDEST reasons Britons needed NHS treatment last year
EXCL: MailOnline analysed official NHS England data to uncover some of strangest causes of a hospital admission over the last year.
Source: the Mail online | Health - September 21, 2023 Category: Consumer Health News Source Type: news

Gabapentin No Help for Lingering COVID-Induced Olfactory Dysfunction
(MedPage Today) -- Treatment with oral gabapentin did not improve olfactory dysfunction that remained 3 months after a COVID-19 infection, the randomized GRACE trial showed. Of 44 patients who completed the 8-week fixed-dose phase, 44% of those...
Source: MedPage Today Infectious Disease - September 21, 2023 Category: Infectious Diseases Source Type: news

ICB hands urgent treatment centres to trusts after ending firm’s contract
An integrated care board has handed the operation of six urgent treatment centres to trusts after terminating a private provider’s contract.
Source: HSJ - September 21, 2023 Category: UK Health Source Type: news

Most Adults With Alopecia Areata Untreated 1 Year After Dx Most Adults With Alopecia Areata Untreated 1 Year After Dx
In the study, two-thirds of newly diagnosed patients had received at least one treatment within the first year of diagnosis.Medscape Medical News
Source: Medscape Dermatology Headlines - September 21, 2023 Category: Dermatology Tags: Dermatology News Source Type: news

FDA Opted Not to Approve Neffy Yet
WEDNESDAY, Sept. 20, 2023 -- In a surprising move, the U.S. Food and Drug Administration has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions. Approval of the Neffy (epinephrine)...
Source: Drugs.com - Pharma News - September 20, 2023 Category: Pharmaceuticals Source Type: news

FDA Wants More Data on First Needle-Free Antidote for Severe Allergic Reactions
WEDNESDAY, Sept. 20, 2023 -- In a surprising move, the U.S. Food and Drug Administration has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions. Approval of the Neffy (epinephrine) nasal...
Source: Drugs.com - Pharma News - September 20, 2023 Category: Pharmaceuticals Source Type: news

A Top New York Hospital, an Unapproved Treatment and an F.D.A. Warning
A product made from umbilical cord blood was used in spine surgeries at a Manhattan hospital. After a federal warning came an internal complaint: Patients should have been told.
Source: NYT Health - September 20, 2023 Category: Consumer Health News Authors: Ellen Gabler, Steve Eder and Allie Pitchon Tags: Hospitals Blood Biotechnology and Bioengineering Ethics and Official Misconduct New York-Presbyterian Hospital Food and Drug Administration Surgery and Surgeons Regulation and Deregulation of Industry Medicine and Health Research Burst Source Type: news

NIH researchers develop new method to identify potential stroke therapies
First-of-its-kind study points to uric acid as a promising treatment for further investigation.
Source: National Institutes of Health (NIH) News Releases - September 20, 2023 Category: American Health Source Type: news

Researchers develop new method to identify potential stroke therapies
First-of-its-kind study points to uric acid as a promising treatment for further investigation.
Source: National Institutes of Health (NIH) News Releases - September 20, 2023 Category: American Health Source Type: news

Glaucoma: A Hidden Threat to Vision Health Rising Swiftly
It's predicted that by 2050, the number of people with glaucoma will surge by more than 200%, highlighting an urgent need for heightened awareness, early detection, and advanced treatment strategies.
Source: WebMD Health - September 20, 2023 Category: Consumer Health News Source Type: news

FDA Wants More Data on First Needle-Free Antidote for Severe Allergic Reactions
WEDNESDAY, Sept. 20, 2023 -- In a surprising move, the U.S. Food and Drug Administration (FDA) has opted not to approve a needle-free alternative to the EpiPen for emergency treatment of severe allergic reactions. Approval of the Neffy nasal spray...
Source: Drugs.com - Daily MedNews - September 20, 2023 Category: General Medicine Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20